Megace and Elocon drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Megace (megestrol acetate) and Elocon (mometasone furoate). Common drug interactions include visual impairment among females and ileus paralytic among males.

The phase IV clinical study analyzes what interactions people have when they take Megace and Elocon. It is created by eHealthMe based on reports of 15 people who take the same drugs from the FDA, and is updated regularly.

What is Megace?

Megace has active ingredients of megestrol acetate. It is often used in weight loss. eHealthMe is studying from 10,095 Megace users. Check the latest studies of Megace.

What is Elocon?

Elocon has active ingredients of mometasone furoate. It is often used in eczema. eHealthMe is studying from 2,019 Elocon users. Check the latest studies of Elocon.

On Jul, 09, 2026

15 people who take Megace and Elocon together, and have interactions are studied.

What are the common drug interactions of Megace and Elocon, by gender? *:

female:

Visual impairment
Vomiting
Weight decreased
Abasia (inability to walk)
Abdominal distension
Abdominal pain
Abdominal pain upper
Anaemia of chronic disease
Anxiety
Asthenia (weakness)

male:

Ileus paralytic (obstruction of the intestine due to paralysis of the intestinal muscles)
Renal failure (kidney dysfunction)
Pharyngitis streptococcal (inflammation of the pharynx caused by infection from. streptococcus)
Tachyarrhythmia (disturbance of the heart rhythm in which the heart rate is abnormally increased)
Tachycardia (a heart rate that exceeds the range of 100 beats/min)
Vomiting
Haematotoxicity (toxins that destroy red blood cells)
General physical health deterioration (weak health status)
Abdominal distension
Abdominal pain

What are the common drug interactions of Megace and Elocon, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

Pharyngitis streptococcal (inflammation of the pharynx caused by infection from. streptococcus)

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

Diabetic ketoacidosis (diabetic ketoacidosis (dka) is high concentrations of ketone bodies)

60+:

Renal failure (kidney dysfunction)
Ileus paralytic (obstruction of the intestine due to paralysis of the intestinal muscles)
Abasia (inability to walk)
Abdominal pain upper
Anaemia of chronic disease
Anuria (failure of the kidneys to produce urine)
Anxiety
Asthenia (weakness)
Ataxia (loss of full control of bodily movements)
Atelectasis (partial or complete collapse of the lung)

What are the existing conditions these people have? *

Lung Cancer - Non-Small Cell (lung cancer): 10 people, 66.67%
Rashes (redness): 8 people, 53.33%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 6 people, 40.00%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 5 people, 33.33%
Alcoholism (problems with alcohol): 4 people, 26.67%
Fever: 1 person, 6.67%
Eye Pruritus (eye itching): 1 person, 6.67%
Eye Irritation: 1 person, 6.67%
Dry Eyes (lack of adequate tears): 1 person, 6.67%
Device Related Infection: 1 person, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Megace and Elocon?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously